NEW YORK, NY--(Marketwired - Aug 20, 2014) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Lions Gate Entertainment Corp. ("Lions Gate" or the "Company") (NYSE: LGF) securities between February 11, 2013 and March 13, 2014.
For more information, click here: http://zlk.9nl.com/lions-gate-entertainment-lgf.
The complaint alleges that Lions Gate and certain of its executives violated federal securities laws by failing to disclose and/or misrepresenting the existence of an SEC investigation, the prospect of legal proceedings associated with the alleged misconduct under investigation, and the exposure of the Company to loss in connection with said investigation and alleged misconduct. It is further alleged that the Company misled investors and/or failed to adequately disclose the nature of a series of transactions between the Company and investor Carl Icahn.
On March 13, 2014, the SEC issued an Order that described the investigation and noted that Lions Gate settled the investigation by, among other things, agreeing to pay $7.5 million in fines and acknowledging that it had violated federal securities laws.
If you suffered a loss in Lions Gate you have until September 9, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/lions-gate-entertainment-lgf.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.